Treatment of refractory bleeding after cardiac operations with low-dose recombinant activated factor VII (NovoSeven®): a propensity score analysis

European Journal of Cardio-thoracic Surgery

Volumn 33, Issue 1, 2008, Pages 64-71

  Gelsomino, Sandro ^a   Lorusso, Roberto ^b   Romagnoli, Stefano ^a   Bevilacqua, Sergio ^a   De Cicco, Giuseppe ^b   Billè, Giuseppe ^a   Stefàno, Pierluigi ^a   Gensini, Gian Franco ^c  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b Civic Hospital   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Hemorrhage; Plasma; Platelet derived factors; Platelets

Indexed keywords

APROTININ; FRESH FROZEN PLASMA; HEPARIN; PROTAMINE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD TRANSFUSION; BOLUS INJECTION; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; FORWARD HEART FAILURE; HEART SURGERY; HEART VALVE SURGERY; HEMOSTASIS; HUMAN; INFECTION; INTENSIVE CARE UNIT; INTERNATIONAL NORMALIZED RATIO; KIDNEY FAILURE; LENGTH OF STAY; LOW DRUG DOSE; MALE; MULTIPLE ORGAN FAILURE; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTHROMBIN TIME; RESPIRATORY FAILURE; SCORING SYSTEM; STROKE; THROMBOCYTE COUNT; THROMBOEMBOLISM; THROMBOSIS; TREATMENT INDICATION; TREATMENT OUTCOME;

AGED; BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; COAGULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FACTOR VIIA; FEMALE; HUMANS; MALE; POSTOPERATIVE HEMORRHAGE; RECOMBINANT PROTEINS; TREATMENT OUTCOME;

EID: 37249052687     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2007.10.004     Document Type: Article

References (25)

1. Warren O., Mandal K., Hadjianastassiou V., Knowlton L., Panesar S., John K., Darzi A., and Athanasiou T. Recombinant activated factor VII in cardiac surgery: a systematic review. Ann Thorac Surg 83 2 (2007) 707-714
2. Hedner U. Recombinant factor VIIa: its background, development and clinical use. Curr Opin Hematol 14 3 (2007) 225-229
3. Connell K.A., Wood J.J., Wise R.P., Lozier J.N., and Braun M.M. Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. JAMA 295 (2006) 293-298
4. Lodge J.P., Jonas S., Oussoultzoglou E., Malagó M., Jayr C., Cherqui D., Anthuber M., Mirza D.F., Kuhlman L., Bechstein W.O., Díaz J.C., Tartiere J., Eyraud D., Fridberg M., Erhardtsen E., and Mimoz O. Recombinant coagulation factor VIIa in major liver resection: a randomized, placebo-controlled, double-blind clinical trial. Anesthesiology 102 (2005) 269-275
5. Kirklin J.W., and Barrat Boyes B. Morphology, diagnostic criteria, natural history, techniques, result and indications. In: Kirklin J.W., and Barrat Boyes B. (Eds). Cardiac surgery (1997), Churchill Livingstone, Philadelphia 195-253
6. Hensley F.A., Martin D.E., and Gravlee G.P. A practical approach to cardiac anesthesia. 3rd ed. (2003), Lippincott Williams & Wilkins, Philadelphia pp. 495-498
7. Mayer S.A., Brun N.C., Begtrup K., Broderick J., Davis S., Diringer M.N., Skolnick B.E., Steiner T., and Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 352 (2005) 777-785
8. Yasaka M., Sakata T., Naritomi H., and Minematsu K. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation. Thrombosis Res 115 (2005) 455-459
9. Nuttall G.A., Stehling L.C., Beighley C.M., Faust R.J., and American Society of Anesthesiologists Committee on Transfusion Medicine. Current transfusion practices of members of the American society of anesthesiologists: a survey. Anesthesiology 99 6 (2003) 1433-1443
10. Rosembaum P.R., and Rubin D.B. The central role of the Propensity Score in observational studies for causal effects. Biometrika 70 (1983) 41-55
11. Parsons, LS. Using SAS Software to Perform a Case-Control Match on Propensity Score in an Observational Study. In: Proceedings of the Twenty-Fifth Annual SAS Users Group International Conference, Cary, NC: SAS Institute Inc. 2000; 1166-1171.
12. Feinstein A.R. Multiple logistic regression. In: Feinstein A.R. (Ed). Multivariable analysis: an introduction (1996), Yale University Press, New Haven 297-330
13. Parsons LS. Reducing bias in a propensity score match-pair sample using greedy matching techniques. In: Proceedings of the 26th Annual SAS Users Group International Conference. Cary, NC: SAS Institute Inc. 2001;214-26.
14. Lin D.Y., Psaty B.M., and Kronmal R.A. Assessing the sensitivity of regression results to unmeasured confounders in observational studies. Biometrics 54 (1998) 948-963
15. Tanaka K.A., Waly A.A., Cooper W.A., and Levy J.H. Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant factor VIIa (NovoSeven). Anesthesiology 98 (2003) 1513-1515
16. Tobias J.D., Simsic J.M., Weinstein S., Schechter W., Kartha V., and Michler R. Recombinant factor VIIa to control excessive bleeding following surgery for congenital heart disease in pediatric patients. J Inten Care Med 19 (2004) 270-273
17. Raivio P., Suojaranta-Ylinen R., and Kuitunen A.H. Recombinant factor VIIa in the treatment of postoperative hemorrhage after cardiac surgery. Ann Thorac Surg 80 (2005) 66-71
18. Karkouti K., Beattie W.S., Dattilo K.M., McCluskey S.A., Ghannam M., Hamdy A., Wijeysundera D.N., Fedorko L., and Yau T.M. Recombinant factor VIIa for intractable blood loss after cardiac surgery: a propensity score-matched case control analysis. Transfusion 45 (2005) 26-34
19. O'Connel K.A., Wood J.J., Wise R.P., Lozier J.N., and Braun M.M. Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. JAMA 295 (2006) 293-298
20. Chung J.H., Gikakis N., Rao A.K., Drake T.A., Colman R.W., and Edmunds Jr. L.H. Pericardial blood activates the extrinsic coagulation pathway during clinical cardiopulmonary bypass. Circulation 93 (1996) 2014-2018
21. Donahue B.S., Gailani D., and Mast A. Disposition of tissue factor pathway inhibitor during cardiopulmonary bypass. J Thromb Haemost 4 5 (2006) 1011-1016
22. Bevan D.H. Cardiac bypass haemostasis: putting blood through the mill. Br J Haematol 104 2 (1999) 208-219
23. Sørensen B., and Ingerslev J. A direct thrombin inhibitor studied by dynamic whole blood clot formation. Thromb and Haemost 96 (2006) 446-453
24. Dickneite G. Prothrombin complex concentrate versus recombinant factor VIIa for reversal of coumarin anticoagulation. Thromb Res 119 (2007) 643-651
25. Geoffrey A., Allen G.A., Hoffman M., Roberts H.R., and Monroe D.M. Manipulation of prothrombin concentration improves response to high-dose factor VIIa in a cell-based model of haemophilia. Br J Haematol 134 (2006) 314-319